Chlamydial antibodies among copper T intrauterine contraceptive device users
Ain-Shams Medical Journal. 2000; 51 (4-6): 503-513
em Inglês
| IMEMR
| ID: emr-53205
ABSTRACT
Approximately 60 million women use the intrauterine contraceptive devices [IUCD] worldwide. IUCD constitutes one of the most accepted and widely used methods of contraception especially in the developing countries. Several studies have demonstrated an increased risk of pelvic inflammatory disease [PID] in women using intrauterine contraceptive devices. The role of chlamydia trachomatis in causing PID among IUCD users is not clear. This prospective study aims to clarify the effect of copper T IUCD on the incidence of chlamydia trachomatis infection in the female genital tract. This was done by measuring anti-chlamydia antibodies in the serum of copper T IUCD users compared to non-users among 100 patients attending Family Planning Clinic in Ain Shams University Maternity Hospital. The results showed that Chlamydia antibodies were significantly higher [P < 0.01] among IUCD users compared to non-users. In addition, on linking diagnostic criteria of chlamydia trachomatis infection to the mean serology of chlamydial antibodies, there was no significant correlation to serology [P > 0.05]. This indicates the silent nature of this infection and the importance of screening of chlamydia trachomatis among women at riskor acquiring this infection
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Infecções por Chlamydia
/
Chlamydia trachomatis
/
Dispositivos Anticoncepcionais Femininos
/
Anticorpos
Limite:
Feminino
/
Humanos
Idioma:
Inglês
Revista:
Ain-Shams Med. J.
Ano de publicação:
2000
Similares
MEDLINE
...
LILACS
LIS